Anti-Human CD3E Recombinant Antibody(Otelixizumab)

Name: Anti-Human CD3E Recombinant Antibody(Otelixizumab)
Brand: KMD Bioscience
SKU: YR1152

YR1152

科研级 Otelixizumab ( 奥昔组单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Otelixizumab

DATASHEET MSDS

Product Description

Alias	科研级 Otelixizumab ( 奥昔组单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Otelixizumab
Catalog Number	YR1152
Molecular Name	Otelixizumab
Host	Rat
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Lambda
Formulation	PBS, pH7.5
Background	Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.
CAS Number	881191-44-2
Application	FCM, IP, ELISA, Neut, FuncS, IF, WB
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD3E[Homo sapiens]

Login